Pear Therapeutics, Inc.·4

Dec 7, 5:26 PM ET

Snow Ellen 4

4 · Pear Therapeutics, Inc. · Filed Dec 7, 2021

Insider Transaction Report

Form 4
Period: 2021-12-03
Snow Ellen
Chief Accounting Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-12-03+265,034265,034 total
    Exercise: $1.40Exp: 2031-04-28Common Stock (265,034 underlying)
Footnotes (2)
  • [F1]25% of the shares underlying the option vested or shall vest on March 29, 2022 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
  • [F2]Received in accordance with the terms of the Business Combination Agreement (the "Business Combination Agreement") dated as of June 21, 2021, by and among Thimble Point Acquisition Corp., Oz Merger Sub, Inc. and Pear Therapeutics (US), Inc. (f/k/a Pear Therapeutics, Inc.) ("Private Pear"), in exchange for an option to acquire 180,000 shares of common stock of Private Pear for $2.06 per share.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES